|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_MaterialEventDisclosureGeneralAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
-
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
Acting with the aim of becoming an important global actor in the pharmaceutical industry, Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş. (" GEN") follows the strategy of expanding its activities abroad in line with this aim. In line with this strategy, the Board of Directors of GEN has decided to open a Representative Office in Tbilisi, the capital of Georgia, in order to carry out marketing activities of products which are manufactured or registered by GEN or products which will be manufactured or registered by GEN and to carry out market research. With Georgia Representative Office , GEN will begin to operate in a new market, and it is considered that the Representative Office will expand the global activities of GEN and positively affect its sales. In addition to the Azerbaijan, Russia, Kazakhstan, Uzbekistan and Germany offices, Georgia Representative Office will operate as GEN's sixth office abroad. |
||||||||